Medovate develops medical devices and innovation solutions in conjunction with the NHS to address unmet clinical needs. The company works through the full medical device development pipeline, from idea to market adoption.

Medovate

Med-Tech Innovation Expo is a trade show and exhibition focusing on the medical device manufacturing sector, bringing together professionals from the industry.

Med-Tech Innovation Expo

Medovate Limited | 1,535 followers on LinkedIn. Dynamic medical device company developing innovative new technologies from the NHS and beyond to improve patient care. | Medovate is a dynamic medical innovation development company dedicated to bringing novel medical technologies, created within the NHS, to market to improve patient care.

Backed by investment capital from NVM Private Equity and a private US investor, Medovate is the first company dedicated to the development and commercialisation of innovative medical technologies from within the NHS.

By providing funding at a crucial point in development, Medovate will ensure that medtech innovations with high potential identified within the NHS are supported through the clinical trial and regulatory approval phases so that they become products that are ready for market as quickly as possible.

Vice President Business Development

Stuart Thomson

Clinical Trainer - MEDOVATE / JEB Technologies LTD

Samuel Pearce

Operations Coordinator at Medovate Limited

Callum Mcmanners

Medovate Limited

It’s the final day of the MEDICA 2024 show!! If you haven’t already, make sure to visit the Medovate and JEB Technologies stand in Hall 15 C24-2. You can meet the team to find out more about our products and manufacturing capabilities, or if you are unable to visit the stand contact sales@medovate.co.uk #medica24 #medtechinnovation #prostatebiopsy #anaesthesia

Visit the Medovate and JEB Technologies team for day 2 of Medica 2024! We are showcasing a product portfolio including CamPROBE and SAFIRA, as well as our product development and manufacturing capabilities #manufacturing #medtechinnovation #prostatebiopsy #regionalanaesthesia

MEDICA 2024! The Medovate and JEB Technologies stand is all set up for day 1 at #medica24 Visit hall 15 stand C24-2 to find out more about our products and design, development and manufacturing capabilities! #medica24

Medica 2024, here we come! 👏 Our products are on their way, and the excitement is building as we prepare to attend one of the most prestigious medical events of the year. We can’t wait to see you there! Hall 15 Stand C24.2 #MEDICA2024 #Urology #Regionalanesthesia #Dusseldorf #Medical #innovations

GETTING READY! We are thrilled to announce our participation at #Medica 2024 in Düsseldorf, Germany, from November 11-14, Hall 15, Stand C24.2. Join us to explore our latest medical device innovations and gain insights into our future developments. #RegionalAnesthesia #PainManagement #NerveBlocks #Medtech #SAFIRA #Urology #Biopsy #CamPROBE

You still have time today and tomorrow to see #SAFIRA , our unique single-operator device for Regional Anesthesia. We've had great interest so far and welcome more visitors to #Medovate Booth number 23 until the end of the event. #RegionalAnesthesia #PainManagement #NerveBlocks #Medtech

Come and visit us at Stand 29 @ #NSC24 to learn more about our Accufuser Elastomeric device directly from the manufacturers who have travelled from Korea to support the conference

LTR Medical

Day one is off to a fantastic start! Our team is buzzing with activity as attendees visit our booth to experience the #SAFIRA product first-hand. It’s been non-stop action! Come and see us at Booth 23 – we’d love to show you what SAFIRA can do! #Innovation #MedicalDevices #ESRA2024 #Medovate

Come and join us at the #ESRA 2024 Congress in Prague , 4 - 7 September, on booth 23. The team will be there to provide you with a hands on experience, showcasing our innovative #SAFIRA ® Device. We are looking forward to seeing you on our booth! #Medovate #ESRA #RegionalAnesthesia #PainTherapy #MedicalDevice

We're thrilled to announce that Medovate Limited , a Cambridge-based medical device development company, has signed a distribution agreement with Temena Group , headquartered in Germany. This partnership grants Temena distribution rights for our innovative #SAFIRA ® (SAFer Injection for Regional Anaesthesia) technology across Germany, France, Italy, and Spain. SAFIRA® has been developed in collaboration with anaesthetists from the #NHS and aims to revolutionise regional anaesthesia practice, enhancing patient safety. This groundbreaking system transforms the traditional two-person procedure into a one-person operation, giving anaesthetists full control. With its unique built-in safety feature, SAFIRA® automatically stops injections at a calibrated threshold, reducing the risk of nerve damage from high-pressure injections. Temena, founded in 1985 by Wilhelm Waskönig, brings over thirty-five years of expertise in locoregional anaesthesia to the table. Their commitment to patient-centred care and extensive experience with public and private healthcare organisations make them an ideal partner for distributing SAFIRA®. Join us in celebrating this significant milestone as we continue to innovate and improve patient outcomes in regional anaesthesia. #Medovate #SAFIRA #HealthcareInnovation #PatientSafety #Anaesthesia #MedTech #Temena #Partnership #MedicalDevices

Metric
Company Name	Medovate	Med-Tech Innovation Expo
Symbol
MSH ID	UK:CO:MEDOVATE	COM:MED-TECHEXPO
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical Devices	Medical Device Manufacturing
Country	GB	GB
Stage	Private Equity Round
Employee Count
Website	medovate.co.uk	med-techexpo.com
LinkedIn	medovate-ltd	med-tech-innovation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	88
Web Traffic Growth	-0.95
Valuation
Raised Capital	11.99M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CO

UK:CO:MEDOVATE

Medovate

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue